Xiaojuan Zang
Research Subjects
Research Interests
Xiaojuan Zang has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Xiuxiu Hu
School of Medical Technology, Jiangsu College of Nursing, Huai'an, Jiangsu 22300, P.R. China
1 shared publication- Yanguan Lv
The Huai’an Maternity and Child Clinical College of Xuzhou Medical University, Huai’an, People’s Republic of China
1 shared publication
Latest Publications
- Open Access
- 29 March 2021
- Published by Spandidos Publications in Oncology Letters
- Vol. 21 (5) , 1-11
Detection of circulating tumor cells: Advances and critical concerns (Review)
Metastasis is the main cause of cancer‑related death and the major challenge in cancer treatment. Cancer cells in circulation are termed circulating tumor cells (CTCs). Primary tumor metastasis is likely due to CTCs released into the bloodstream. These CTCs extravasate and form fatal metastases in different organs. Analyses of CTCs are clarifying the biological understanding of metastatic cancers. These data are also helpful to monitor disease progression and to inform the development of personalized cancer treatment‑based liquid biopsy. However, CTCs are a rare cell population with 1‑10 CTCs per ml and are difficult to isolate from blood. Numerous approaches to detect CTCs have been developed based on the physical and biological properties of the cells. The present review summarizes the progress made in detecting CTCs.
- 29 March 2021
- Published by Spandidos Publications in Oncology Letters
- Vol. 21 (5) , 1-11
Open AccessDetection of circulating tumor cells: Advances and critical concerns (Review)
Metastasis is the main cause of cancer‑related death and the major challenge in cancer treatment. Cancer cells in circulation are termed circulating tumor cells (CTCs). Primary tumor metastasis is likely due to CTCs released into the bloodstream. These CTCs extravasate and form fatal metastases in different organs. Analyses of CTCs are clarifying the biological understanding of metastatic cancers. These data are also helpful to monitor disease progression and to inform the development of personalized cancer treatment‑based liquid biopsy. However, CTCs are a rare cell population with 1‑10 CTCs per ml and are difficult to isolate from blood. Numerous approaches to detect CTCs have been developed based on the physical and biological properties of the cells. The present review summarizes the progress made in detecting CTCs.